Biotechnology Cancer Cures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (105)	1/22/2000 1:21:00 AM
From: Mike McFarland	Read Replies (1) of 226

Melanoma etc just setting up a subthread path for myself NEW VISTAS IN CANCER TREATMENT Message 12633122 disclaimer... I don't own biom with a marketcap of 575m, or crxa--450m, or pgnx--632m, or vicl--640m... but I down own gzmo, with a marketcap of 127m Genzyme's Molecular Oncology, clinical trial in melanoma--gene therapy vaccine--two of most widely-expressed melanoma tumor antigens... Melan-A/MART-1 and gp100. They have other stuff too.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next